Interestingly, overexpression of LARGE causes hyperglycosylation of α-DG with increased ligand-binding activity not only in wild-type and Large-deficient muscle cells, but also in cells from WWS, MEB, FCMD patients and mouse models37. Here, LARGE1 is linked to muscular dystrophy-dystroglycanopathy, type A.